By Nick Stride
Friday 16th November 2001 |
Text too small? |
"The first one's always expensive and the second one's always cheap because you've got the synergies," Mr Cairns told the National Business Review.
Lion's $A7.20 a share offer has secured more than 90% of Petaluma's shares and it will compulsorily acquire the remainder.
Lion is also offering $A1.15 offer a share for Banksia wines and has 21%.
If the Banksia offer is successful the two companies will have cost Lion $A297 million ($367 million).
Mr Cairns said the "blended" price for the two offers valued the companies at 13.5 times earnings before interest, tax, depreciation and amortisation, well within the range for recent wine acquisitions.
He rejected criticism from some analysts that Lion had walked away from an overpriced Montana only to pay over the odds for Petaluma.
Petaluma had four distinct and unique advantages, he said, three of which Montana lacked.
It had genuine icon brands - Petaluma Chardonnay, Petaluma Cabinet Sauvignon, and Croser methode champenoise.
All three scored 90 points or more out of 100 in wine critic James Halliday's annual rating of Australian wines.
It had premium pricing - the average retail price a bottle for Petaluma's 387,000 cases of annual sales was $A36.
It had its own Australian selling and distribution system.
And it had a US distribution system, a joint venture with Stimson Lane.
Lion's first priority was to consolidate its Australian assets and to develop the Stimson venture.
At some stage it was keen to add a Marlborough Sauvignon Blanc to its range.
The investments were expected to dilute Lion's earnings a share by 1c until 2004 but earnings would exceed the cost of capital from 2005.
No comments yet
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme